Model
Edge
Reata Pharmaceuticals, Inc
0001358762
Filing Type
8-K
Filing Date
9/25/2023
Updated
9/26/23, 11:25 AM
Filing
8-K
Earnings Release
Exhibits
8-K
End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
EX-3.1
EX-3.1
EX-3.2
EX-3.2
EX-3.3
EX-3.3
EX-3.4
EX-3.4